SLE (Systemic Lupus)
Conditions
Keywords
SLE, Lupus erythematosus, Outcomes, Phenotypes, Observational
Brief summary
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adult patients defined as age greater than 18 years old. 2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria). 3. No restriction on time of diagnosis.
Exclusion criteria
* Patients who don't fulfil classification criteria mentioned above.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Disease Accrual damage among SLE patients in Saudi Arabia | over 10 years | SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2000 (0-150) higher score representing higher disease activity |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient reported outcome | over 5 years | PROMIS ( Patient Reported Outcome Measurement Information Scale) there are several data collection tool for calculating score (will use REDCap auto score). Each question usually has 5 response option ranging in value from one to five. For example, the adult 8-item, the lowest possible score is 8, the highest possible score is 40 |
| Fetal and maternal outcomes in patients with SLE | over 5 years | Intrauterine fetal death, Abortion, Still birth, Eclampsia and pre-eclampsia, disease Activity |
Countries
Saudi Arabia